Microbial and Natural Metabolites That Inhibit Splicing: A Powerful Alternative for Cancer Treatment
![Frontiers | Innovative Therapeutic and Delivery Approaches Using Nanotechnology to Correct Splicing Defects Underlying Disease | Genetics Frontiers | Innovative Therapeutic and Delivery Approaches Using Nanotechnology to Correct Splicing Defects Underlying Disease | Genetics](https://www.frontiersin.org/files/Articles/520004/fgene-11-00731-HTML-r1/image_m/fgene-11-00731-g001.jpg)
Frontiers | Innovative Therapeutic and Delivery Approaches Using Nanotechnology to Correct Splicing Defects Underlying Disease | Genetics
![A phase I, open-label, single-arm, dose-escalation study of E7107, a precursor messenger ribonucleic acid (pre-mRNA) splicesome inhibitor administered intravenously on days 1 and 8 every 21 days to patients with solid tumors A phase I, open-label, single-arm, dose-escalation study of E7107, a precursor messenger ribonucleic acid (pre-mRNA) splicesome inhibitor administered intravenously on days 1 and 8 every 21 days to patients with solid tumors](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10637-013-0046-5/MediaObjects/10637_2013_46_Fig1_HTML.gif)
A phase I, open-label, single-arm, dose-escalation study of E7107, a precursor messenger ribonucleic acid (pre-mRNA) splicesome inhibitor administered intravenously on days 1 and 8 every 21 days to patients with solid tumors
![Cancers | Free Full-Text | Somatic Mutations in Core Spliceosome Components Promote Tumorigenesis and Generate an Exploitable Vulnerability in Human Cancer | HTML Cancers | Free Full-Text | Somatic Mutations in Core Spliceosome Components Promote Tumorigenesis and Generate an Exploitable Vulnerability in Human Cancer | HTML](https://www.mdpi.com/cancers/cancers-14-01827/article_deploy/html/images/cancers-14-01827-g001.png)
Cancers | Free Full-Text | Somatic Mutations in Core Spliceosome Components Promote Tumorigenesis and Generate an Exploitable Vulnerability in Human Cancer | HTML
![Scalable Synthesis of 17S-FD-895 Expands the Structural Understanding of Splice Modulatory Activity - ScienceDirect Scalable Synthesis of 17S-FD-895 Expands the Structural Understanding of Splice Modulatory Activity - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S266638642030299X-fx1.jpg)
Scalable Synthesis of 17S-FD-895 Expands the Structural Understanding of Splice Modulatory Activity - ScienceDirect
![The catalytic spliceosome inhibitor E7107 induces IR and has potent... | Download Scientific Diagram The catalytic spliceosome inhibitor E7107 induces IR and has potent... | Download Scientific Diagram](https://www.researchgate.net/publication/340837111/figure/fig1/AS:883109650247681@1587561156139/The-catalytic-spliceosome-inhibitor-E7107-induces-IR-and-has-potent-anti-MM-activity-in_Q640.jpg)
The catalytic spliceosome inhibitor E7107 induces IR and has potent... | Download Scientific Diagram
![A phase I, open-label, single-arm, dose-escalation study of E7107, a precursor messenger ribonucleic acid (pre-mRNA) splicesome inhibitor administered intravenously on days 1 and 8 every 21 days to patients with solid tumors A phase I, open-label, single-arm, dose-escalation study of E7107, a precursor messenger ribonucleic acid (pre-mRNA) splicesome inhibitor administered intravenously on days 1 and 8 every 21 days to patients with solid tumors](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10637-013-0046-5/MediaObjects/10637_2013_46_Fig2_HTML.gif)
A phase I, open-label, single-arm, dose-escalation study of E7107, a precursor messenger ribonucleic acid (pre-mRNA) splicesome inhibitor administered intravenously on days 1 and 8 every 21 days to patients with solid tumors
![Splicing modulation as novel therapeutic strategy against diffuse malignant peritoneal mesothelioma - ScienceDirect Splicing modulation as novel therapeutic strategy against diffuse malignant peritoneal mesothelioma - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2352396418306029-gr2.jpg)
Splicing modulation as novel therapeutic strategy against diffuse malignant peritoneal mesothelioma - ScienceDirect
![The catalytic spliceosome inhibitor E7107 induces IR and has potent... | Download Scientific Diagram The catalytic spliceosome inhibitor E7107 induces IR and has potent... | Download Scientific Diagram](https://www.researchgate.net/publication/340837111/figure/fig1/AS:883109650247681@1587561156139/The-catalytic-spliceosome-inhibitor-E7107-induces-IR-and-has-potent-anti-MM-activity-in.png)
The catalytic spliceosome inhibitor E7107 induces IR and has potent... | Download Scientific Diagram
![Roles and mechanisms of alternative splicing in cancer — implications for care | Nature Reviews Clinical Oncology Roles and mechanisms of alternative splicing in cancer — implications for care | Nature Reviews Clinical Oncology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41571-020-0350-x/MediaObjects/41571_2020_350_Fig1_HTML.png)
Roles and mechanisms of alternative splicing in cancer — implications for care | Nature Reviews Clinical Oncology
![Therapeutic Modulation of RNA Splicing in Malignant and Non-Malignant Disease: Trends in Molecular Medicine Therapeutic Modulation of RNA Splicing in Malignant and Non-Malignant Disease: Trends in Molecular Medicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/75ef1ee5-f40c-48c6-97a4-6cb6e521c6f7/gr1_lrg.jpg)
Therapeutic Modulation of RNA Splicing in Malignant and Non-Malignant Disease: Trends in Molecular Medicine
![Proteasome inhibitor-induced modulation reveals the spliceosome as a specific therapeutic vulnerability in multiple myeloma | bioRxiv Proteasome inhibitor-induced modulation reveals the spliceosome as a specific therapeutic vulnerability in multiple myeloma | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2019/02/03/508549/F6.large.jpg)
Proteasome inhibitor-induced modulation reveals the spliceosome as a specific therapeutic vulnerability in multiple myeloma | bioRxiv
![IJMS | Free Full-Text | Therapeutic Targeting of Alternative RNA Splicing in Gastrointestinal Malignancies and Other Cancers | HTML IJMS | Free Full-Text | Therapeutic Targeting of Alternative RNA Splicing in Gastrointestinal Malignancies and Other Cancers | HTML](https://www.mdpi.com/ijms/ijms-22-11790/article_deploy/html/images/ijms-22-11790-g001-550.jpg)
IJMS | Free Full-Text | Therapeutic Targeting of Alternative RNA Splicing in Gastrointestinal Malignancies and Other Cancers | HTML
![A Comprehensive Overview of Structure‐Activity Relationships of Small‐Molecule Splicing Modulators Targeting SF3B1 as Anticancer Agents - Zhang - 2020 - ChemMedChem - Wiley Online Library A Comprehensive Overview of Structure‐Activity Relationships of Small‐Molecule Splicing Modulators Targeting SF3B1 as Anticancer Agents - Zhang - 2020 - ChemMedChem - Wiley Online Library](https://chemistry-europe.onlinelibrary.wiley.com/cms/asset/aa700a94-b428-4b02-bef1-3a82604c42d7/cmdc202000642-fig-0001-m.jpg)
A Comprehensive Overview of Structure‐Activity Relationships of Small‐Molecule Splicing Modulators Targeting SF3B1 as Anticancer Agents - Zhang - 2020 - ChemMedChem - Wiley Online Library
![E7107 induced tumor regression and extended survival in an orthotopic... | Download Scientific Diagram E7107 induced tumor regression and extended survival in an orthotopic... | Download Scientific Diagram](https://www.researchgate.net/publication/329816658/figure/fig4/AS:725288061247488@1549933557389/E7107-induced-tumor-regression-and-extended-survival-in-an-orthotopic-DMPM-mouse-model.png)
E7107 induced tumor regression and extended survival in an orthotopic... | Download Scientific Diagram
![The synthesis and evaluation of the antiproliferative activity of deacidified GEX1A analogues | The Journal of Antibiotics The synthesis and evaluation of the antiproliferative activity of deacidified GEX1A analogues | The Journal of Antibiotics](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fja.2016.166/MediaObjects/41429_2017_Article_BFja2016166_Fig1_HTML.jpg)
The synthesis and evaluation of the antiproliferative activity of deacidified GEX1A analogues | The Journal of Antibiotics
![Dysregulated Alternative Splicing Landscape Identifies Intron Retention as a Hallmark and Spliceosome as a Therapeutic Vulnerability in Aggressive Prostate Cancer | bioRxiv Dysregulated Alternative Splicing Landscape Identifies Intron Retention as a Hallmark and Spliceosome as a Therapeutic Vulnerability in Aggressive Prostate Cancer | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2019/05/11/634402/F7.large.jpg)
Dysregulated Alternative Splicing Landscape Identifies Intron Retention as a Hallmark and Spliceosome as a Therapeutic Vulnerability in Aggressive Prostate Cancer | bioRxiv
![SF3B1 modulators affect key genes in metastasis and drug influx: a new approach to fight pancreatic cancer chemoresistance SF3B1 modulators affect key genes in metastasis and drug influx: a new approach to fight pancreatic cancer chemoresistance](https://oaepublishstorage.blob.core.windows.net/22a5b35f-0321-42ea-9852-6a1c20d88173/4348.fig.1.jpg)